Study finds treatment fails to improve common form of heart failure

December 05, 2008

WINSTON-SALEM, N.C. - A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.

The study, which included researchers at Wake Forest University Baptist Medical Center in key leadership positions, appears in this week's issue of the New England Journal of Medicine, published today.

The findings are disappointing to researchers, who continue to study other medications in search of a successful treatment for the condition, which predominantly affects older individuals, particularly women.

"Heart failure is the only cardiovascular disease on the rise," said Dalane Kitzman, M.D., a cardiologist and professor in the Department of Internal Medicine at Wake Forest Baptist, principal investigator for the Wake Forest Baptist trial site and the national coordinator for the study. "And this newer form of the disease is increasing fastest of all. That's what makes it disconcerting - that we don't have a proven effective treatment. We sort of have to go back to the drawing board."

Doctors long believed that most heart failure was caused by a weakening of the heart muscle that kept it from pumping enough blood out to the body (systolic heart failure). In recent years, however, they have recognized a second and more common form of the disorder in which the heart can empty normally, but does not fill with enough blood (diastolic heart failure). The result is the same - the body does not get enough oxygen-rich blood for its needs. The most common symptom is shortness of breath. Other symptoms include fatigue, swelling around the ankles and high blood pressure.

Few drugs have been tested as treatment strategies in randomized studies of patients with diastolic heart failure - largely because the condition wasn't recognized as a separate form of heart failure until the past decade. To date, no effective treatments have been found.

Wake Forest Baptist researchers and colleagues, both internationally and within the United States, altogether recruited 4,128 patients with the condition from 25 countries. The patients, all of whom were at least 60 years old, were randomly placed into two groups. One group received 300 milligrams of irbesartan, an anti-hypertensive medication marketed as AvaproTM. The other group was given a placebo. Doctors tracked the patients for five years, documenting their progress and outcomes.

The study showed treatment with irbesartan did not reduce the risk of death or hospitalization for cardiovascular causes among patients who had diastolic heart failure, nor did it improve any of the secondary clinical outcomes, including quality of life.

Researchers chose irbesartan for the study because previous, smaller studies in humans with diastolic heart failure indicated that the drug may have had a potential benefit, Kitzman said.

While irbesartan was not successful in treating diastolic heart failure, the study showed the medication, though powerful, was found to be safe for patients with the condition, he said.

There were fewer bad outcomes than predicted, Kitzman added. This may have been partly because blood pressure was well controlled from the start of the study by design. While the results were not positive, Kitzman said, the study does provide helpful clues to treatment of the disease. "If you have the disease but can control blood pressure with medication, the patient is likely to do pretty well," he said.

Because the disease is so common, researchers are continuing work to find effective treatments. Kitzman and colleagues at Wake Forest Baptist are collaborating in another ongoing trial called TOPCAT (Treatment of Preserved Cardiac function heart failure with an Aldosterone anTagonist), testing another medication for treatment of this condition. The study is being funded by the National Institutes of Health. Patients interested in participating can contact (336) 713-4702.

Wake Forest University Baptist Medical Center

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)

Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive working relationship with your doctor or cardiologist.

Living Well with Heart Failure, the Misnamed, Misunderstood Condition
by Edward K. Kasper (Author), Mary Knudson (Author)

Heart failure—the expression alone is scary. The idea that the blood-pumping organ in our chest can struggle, stutter, or suddenly stop is deeply disconcerting. But for those who get the diagnosis, the future is not necessarily bleak. With the right treatments and a healthy lifestyle that includes exercise and good nutrition, many people with heart failure can improve their condition and live well. Heart failure expert Edward K. Kasper, M.D., teams with journalist—and survivor—Mary Knudson to give readers an honest account of this misunderstood condition. The authors explain the complex science of heart failure and look critically at the care available. Living Well with Heart Failure, the Misnamed, Misunderstood Condition will help readers understand:• The causes of the...

Heart Failure: A Companion to Braunwald's Heart Disease: Expert Consult - Online and Print, 2e (Expert Consult Title: Online + Print)
by Douglas L. Mann MD FACC (Author)

Dr. Douglas L. Mann, one of the foremost experts in the field, presents the 2nd Edition of Heart Failure: A Companion to Braunwald's Heart Disease. This completely reworked edition covers the scientific and clinical guidance you need to effectively manage your patients and captures the dramatic advances made in the field over the last five years. Now in full color and with convenient online access, this edition features eleven new chapters, including advanced cardiac imaging techniques, use of biomarkers, cell-based therapies and tissue engineering, device therapies, and much more. Includes access to the complete contents online, fully searchable, enabling you to consult it rapidly from any computer with an Internet connection.
Incorporates an enhanced emphasis on surgical outcomes to...

The Cleveland Clinic Guide to Heart Failure (Cleveland Clinic Guides)
by Randall Starling (Author)

Expert medical advice from the #1 heart center in America for 14 years in a rowFor the 5 million people with heart failure, there’s new reason for hope: recent medical advances have revolutionized how this condition is managed.In The Cleveland Clinic Guide to Heart Failure, Dr. Randall Starling, one of the foremost authorities on heart health, provides authoritative advice to help people survive heart failure and enjoy a good quality of life. This comprehensive resource gives readers the cutting-edge medical guidance Dr. Starling offers his patients, including:
Insight into what causes heart failure;
The latest breakthrough studies – and what those discoveries mean for the future of this disease;
Reliable guidance on diagnostic tests and treatment options;
Personal...

Management of Heart Failure
by Barry Greenberg (Editor), Denise Barnard (Editor), Sanjiv Narayan (Editor), John Teerlink (Editor)

This volume presents a fresh international perspective on current approaches to treating heart failure. An accessible reference for hospital-based specialists, the book provides an update on recent advances in therapeutics and pharmacology, as well as ongoing trials. Four major sections concentrate on a review of screening, assessment and diagnosis; an update on drug treatments; an update on device therapy; and a description of best practice recommendations for managing clinically challenging cases

Oxford Textbook of Heart Failure (Oxford Textbooks in Cardiology)
by Theresa A. McDonagh (Author), Roy S. Gardner (Author), Andrew L. Clark (Author), Henry Dargie (Author)

Although the incidence of coronary heart disease is falling, its major complication, heart failure, is increasing in frequency. All health care practitioners will encounter patients with heart failure, presenting either acutely or in need of chronic heart failure management. However with recent advances in medical therapy, the prognosis of the condition has improved dramatically so that whereas once heart failure was a pre-terminal diagnosis, now for many it is treatable.

Taking the reader from an understanding of the basic mechanisms of heart failure through to an appreciation of the complexities of heart failure management and the remarkable improvements possible with good treatment, this definitive textbook is written by internationally renowned leaders in their field and...

Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT)
by Arnold M. Katz MD (Author), Marvin A. Konstam (Author)

This Second Edition of Dr. Katz's highly acclaimed text has been thoroughly revised to incorporate the latest advances in the study and treatment of heart failure. The book explains the pathophysiology, molecular mechanisms, clinical manifestations, and therapy of heart failure in an integrated, reader-friendly manner that is accessible to both clinicians and basic scientists. More than 100 illustrations, most created for this book by the authors, complement the text. This edition has been completely reorganized. Chapters describe the hemodynamic basis for the clinical manifestations of heart failure; the neurohumoral responses in heart failure and key signaling pathways that mediate functional responses; the proliferative responses in failing hearts; the cellular and molecular...

Heart Failure in Clinical Practice
by Michael Y. Henein (Editor)

Heart Failure in Clinical Practice provides a toolkit for clinicians to guide them in the diagnosis and treatment of patients with suspected heart failure. Algorithms and flow diagrams are included to give the reader an illustrated snapshot of the decisions involved in the management of these patients.

Mechanical Circulatory Support: A Companion to Braunwald's Heart Disease: Expert Consult: Online and Print, 1e
by Robert L. Kormos MD FRCS(C) FACS FAHA (Author), Leslie W. Miller MD (Author)

Mechanical Circulatory Support, by Drs. Robert L. Kormos and Leslie W. Miller, provides the clinically relevant information you need to effectively use this therapy to treat and manage end-stage cardiovascular disease. In this Companion to Braunwald's Heart Disease, the world's most prominent experts in mechanical circulatory support (MCS) cover basic science, device construction, clinical applications, socioeconomic implications, future directions, and more. Stay on top of hot topics - including innovative devices like continuous flow pumps, next-generation centrifugal pumps, and total artificial hearts; MCS for pediatric and congenital heart disease; cellular, molecular, genomic, and functional changes that occur in the failing heart in response to MCS; and Interagency Registry of...

Heart Failure Pocketcard Set
by Anita D. Szady (Author), Anthony A. Bavry (Author)

The Heart Failure pocketcard Set contains a collection of important information on the pathophysiology, diagnosis and management of heart failure including: * Neurohormonal mechanisms of heart failure and common causes of nonischemic cardio myopathy * Heart failure staging information including stage-specific treatment guidelines * The correct assessment and treatment of acute decompensate heart failure * A PRIDE score- and BNP level-based algorithm for the management and triage of patients with suspected acute congestive heart failure * Instructions on the initial evaluation of patients with heart failure including history and physical and laboratory data information * AHA/ACC/HRS guidelines on cardiac defibrillation and resynchronization therapy * Pharmacologic therapy...